Novel Technology Expands the Use of Organs-on-chips
Credit: Wyss Institute at Harvard University
A research team led by scientists from Brigham and Women’s Hospital has developed a novel technology platform that enables the continuous and automated monitoring of so-called “organs-on-chips” — tiny devices that incorporate living cells to mimic the biology of bona fide human organs.
One of the major technical challenges in using organs-on-chips is that current methods for measuring their responses are done mostly by hand, making it difficult to conduct long-term studies that seek to closely model human physiology and responses. Moreover, these measurements require the removal of relatively large volumes of fluid. If repeated several times, they can deplete the liquid in the system, rendering it inoperable.
The scientists, led by first author Yu Shrike Zhang together with senior author Ali Khademhosseini, created several innovations to address these challenges. These include the development of a biochemical sensor that can continuously and accurately measure different substances released by the organ-like system, as well as enhancements that allow the use of multiple physical sensors, which monitor features such as temperature, oxygen levels, and pH values.
In addition, they engineered a central router or “breadboard” that controls fluid flow to different components of the network. Equipped with a series of channels and valves, this breadboard functions as kind of circulatory system that enables researchers to program when and how often liquid runs through specific organs or sensors. The modular design further allows convenient replacement of individual modules when necessary. Zhang and his colleagues were able to use this approach to integrate a variety of different sensors.
“Our system is highly flexible and modular, so it can be readily adapted for use with different types of pre-existing chips and research applications,” explains Zhang. “We hope this will expand the use of organs-on-chips in a variety of contexts, including drug screening and drug toxicity studies,” adds Khademhosseini.
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Shaegh, S. A., . . . Khademhosseini, A. (2017). Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proceedings of the National Academy of Sciences, 201612906. doi:10.1073/pnas.1612906114
This article has been republished from materials provided by Brigham and Women's Hospital. Note: material may have been edited for length and content. For further information, please contact the cited source.
An FDA-approved drug has been identified that, when used with surgery, hampers metastasis in an animal model. Originally developed and approved ~65 years ago to control blood pressure, the medication resperine also prevents what are known as tumor-derived extracellular vesicles from fusing to healthy cells and sharing their cargo of disease-promoting molecules.READ MORE
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
International Conference on Hepatology and Liver Diseases
Jun 10 - Jun 11, 2019